Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07920900
NA

PRP for Sexual Function

Sponsor: Icahn School of Medicine at Mount Sinai

View on ClinicalTrials.gov

Summary

This randomized, single-blinded, sham-controlled trial evaluates whether a single injection of autologous platelet-rich plasma (PRP) into the distal anterior vaginal wall improves sexual function in women with sexual dysfunction. Sixty participants with a Female Sexual Function Index (FSFI) total score of 26.5 or lower are randomized 1:1 to PRP injection or sterile saline injection. Sexual function, sexual distress, global impression of change, and urinary incontinence symptoms are assessed at baseline, 6 weeks, and 6 months after injection.

Official title: Vaginal Injection of Platelet Rich Plasma for Sexual Dysfunction: A Randomized Control Trial

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-08-27

Completion Date

2027-12

Last Updated

2026-11-06

Healthy Volunteers

No

Interventions

BIOLOGICAL

Autologous Platelet-Rich Plasma (PRP) Injection

Whole blood draw of 40 mL is processed by double-spin centrifugation; 4 cc PRP is injected with a 25-guage needle just deep to the epithelium of the distal anterior vaginal wall, about 3 cm from the urethral meatus, after topical lidocaine.

OTHER

Sterile saline injection

4-5cc sterile saline injected at the same location, depth, and technique as the PRP arm, following a blood draw.

Locations (1)

The Mount Sinai Hospital

New York, New York, United States